Meeting
2023 ASCO Annual Meeting
A randomized controlled trial evaluating pretest cancer genetics educational video or in-person genetic counseling.
Authors
Yanin Chavarri Guerra
Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, DF, Mexico
Yanin Chavarri Guerra , Andrea Morales Alfaro , Cesar Alcacio Vzquez , Araceli Carrillo Bedoya , Jazmin Arteaga , Jose Carlos Peñafort Zamora , Sofía Sánchez-Román , Daniela Ramirez Maza , Cynthia Villarreal-Garza , Nancy Reynoso , Alejandro Mohar , Juan Jose Calva Mercado
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Clinical Trial Registration Number
pending
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10597)
DOI
10.1200/JCO.2023.41.16_suppl.10597
Abstract #
10597
Poster Bd #
230
Abstract Disclosures
Similar Posters
First Author: Mallika Sachdev Dhawan
Poster
2023 ASCO Annual Meeting
Women with pathogenic variants in moderate penetrance breast cancer genes: How frequently do they meet high penetrance genetic testing criteria?
First Author: Nicole Casasanta
Poster
2023 ASCO Annual Meeting
Somatic profiling guides germline genetic testing in patients with mutations in cancer predisposition genes.
First Author: Sourat Darabi
Poster
2023 ASCO Annual Meeting
Connecting Black families in Houston, Texas, to hereditary cancer genetic counseling, genetic testing, and cascade testing by using a simple cancer genetic risk assessment and telegenetics.
First Author: Darya Aleksandrovna Kizub